Home > PS Ratio > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of AAREY DRUGS & PHARMACEUTICALS is 0.45.

Share Price ₹54.9Apr 26,2024
Market Cap ₹154.3 Cr
Sales-TTM₹343.4 CrTTM-Standalone Results
Price/Sales0.45xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AAREY DRUGS & PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AAREY DRUGS & PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹154.3 Cr] as on Apr 26,2024

(/) Sales [ ₹343.4 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 0.45x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AAREY DRUGS & PHARMACEUTICALS , the investors are currently willing to pay '0.45 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AAREY DRUGS & PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of AAREY DRUGS & PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of AAREY DRUGS & PHARMACEUTICALS


PS Ratio Performance Analysis for AAREY DRUGS & PHARMACEUTICALS

- AAREY DRUGS & PHARMACEUTICALS 's latest p/e ratio is 0.45x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.16x.

- AAREY DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 0.16x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AAREY DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 0.21x.

- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.1x.


How does AAREY DRUGS & PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AAREY DRUGS & PHARMACEUTICALS 343.40.45154.3
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.61360,920.0
CIPLA LTD25,350.24.49113,794.0
DR REDDYS LABORATORIES LTD27,212.53.83104,316.0
ZYDUS LIFESCIENCES LTD19,024.25.0195,380.9
DIVIS LABORATORIES LTD7,492.814.26106,860.0
MANKIND PHARMA LTD9,946.39.5494,869.4
TORRENT PHARMACEUTICALS LTD10,474.08.6991,057.0
LUPIN LTD19,480.13.7873,642.4
AUROBINDO PHARMA LTD27,894.72.3866,278.5
ABBOTT INDIA LTD5,753.49.5554,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AAREY DRUGS & PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.45x
Max industry PS 14.26x
Median industry PS 5.01x
Average industry PS 6.33x



You may also like the below Video Courses